Search Results 521-530 of 18379 for alopecia
excluding alopecia. - Women of childbearing potential (WCBP) must have a negative urine or serum pregnancy test within 28 days of starting the study drug ...
Adverse events due to previous anti-tumor therapy have not recovered to ≤ CTCAE Grade 1, except alopecia and peripheral neurotoxicity with ≤ CTCAE Grade 2.
Participants with alopecia, stable immune-related toxicity such as hypothyroidism on hormone replacement, adrenal insufficiency treated with ≤10 mg daily ...
Betamethasone topical spray is used to treat adults with mild to moderate plaque psoriasis. This medicine is a corticosteroid (cortisone-like medicine or ...
... alopecia and =< grade 2 neuropathy, which are allowed; Participants with a prior or concurrent malignancy whose natural history or treatment (in the opinion ...
... alopecia. Taxane Naive Patients Only: No prior exposure to taxane therapy of any duration for angiosarcoma. Taxane Pre-treated Patients Only: Prior taxane ...
Role for the epidermal growth factor receptor in chemotherapy-induced alopecia. PLoS One. 2013; 8 (7):e69368 Epub 2013 July 19. View PubMed. PST-20566501. Home ...
... alopecia not requiring systemic treatment, conditions not expected to recur in the absence of an external trigger. Patients with a history of organ ...
Any persistent, unresolved Common Terminology Criteria for Adverse Events (CTCAE) Grade ≥2 drug-related toxicity (except alopecia, erectile impotence ...
Recovered from the effects of any prior surgery, radiotherapy or anti-neoplastic treatment, with the exception of alopecia; Must be able to swallow, retain ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!